{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:59:49Z","timestamp":1793984389719,"version":"4.8.0"},"reference-count":280,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-019-0096-x","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T10:31:36Z","timestamp":1562236296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":457,"title":["Sarcoidosis"],"prefix":"10.1038","volume":"5","author":[{"given":"Johan","family":"Grunewald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth V.","family":"Arkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Moller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"M\u00fcller-Quernheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"96_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/rccm.200608-1197OC","volume":"175","author":"J Grunewald","year":"2007","unstructured":"Grunewald, J. & Eklund, A. Sex-specific manifestations of Lofgren\u2019s syndrome. Am. J. Respir. Crit. Care Med. 175, 40\u201344 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0954-6820.1946.tb10831.x","volume":"124","author":"S L\u00f6fgren","year":"1946","unstructured":"L\u00f6fgren, S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med. Scand. 124, 1\u2013197 (1946).","journal-title":"Acta Med. Scand."},{"key":"96_CR3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.autrev.2009.11.015","volume":"9","author":"A Dubaniewicz","year":"2010","unstructured":"Dubaniewicz, A. Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun. Rev. 9, 419\u2013424 (2010).","journal-title":"Autoimmun. Rev."},{"key":"96_CR4","first-page":"119","volume":"29","author":"MA Judson","year":"2012","unstructured":"Judson, M. A., Boan, A. D. & Lackland, D. T. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc. Diffuse Lung Dis. 29, 119\u2013127 (2012).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR5","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","volume":"48","author":"EV Arkema","year":"2016","unstructured":"Arkema, E. V., Grunewald, J., Kullberg, S., Eklund, A. & Askling, J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur. Respir. J. 48, 1690\u20131699 (2016).","journal-title":"Eur. Respir. J."},{"key":"96_CR6","first-page":"46","volume":"20","author":"KE Byg","year":"2003","unstructured":"Byg, K. E., Milman, N. & Hansen, S. Sarcoidosis in Denmark 1980\u20131994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc. Diffuse Lung Dis. 20, 46\u201352 (2003).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR7","first-page":"50","volume":"7","author":"N Milman","year":"1990","unstructured":"Milman, N. & Selroos, O. Pulmonary sarcoidosis in the Nordic countries 1950\u20131982. Epidemiology and clinical picture. Sarcoidosis 7, 50\u201357 (1990).","journal-title":"Sarcoidosis"},{"key":"96_CR8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman, R. P. et al. Sarcoidosis in America. Analysis based on health care use. Ann. Am. Thorac. Soc. 13, 1244\u20131252 (2016).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"96_CR9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1378\/chest.10-0413","volume":"139","author":"YC Cozier","year":"2011","unstructured":"Cozier, Y. C. et al. Sarcoidosis in black women in the United States: data from the Black Women\u2019s Health Study. Chest 139, 144\u2013150 (2011).","journal-title":"Chest"},{"key":"96_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","volume":"13","author":"O Dumas","year":"2016","unstructured":"Dumas, O., Abramovitz, L., Wiley, A. S., Cozier, Y. C. & Camargo, C. A. Jr Epidemiology of sarcoidosis in a prospective cohort study of U.S. women. Ann. Am. Thorac. Soc. 13, 67\u201371 (2016).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"96_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1183\/09031936.00075307","volume":"31","author":"T Morimoto","year":"2008","unstructured":"Morimoto, T. et al. Epidemiology of sarcoidosis in Japan. Eur. Respir. J. 31, 372\u2013379 (2008).","journal-title":"Eur. Respir. J."},{"key":"96_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12931-018-0871-3","volume":"19","author":"HY Yoon","year":"2018","unstructured":"Yoon, H. Y., Kim, H. M., Kim, Y. J. & Song, J. W. Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir. Res. 19, 158 (2018).","journal-title":"Respir. Res."},{"key":"96_CR13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176859","volume":"12","author":"D Beghe","year":"2017","unstructured":"Beghe, D. et al. Sarcoidosis in an Italian province. Prevalence and environmental risk factors. PLOS ONE 12, e0176859 (2017).","journal-title":"PLOS ONE"},{"key":"96_CR14","first-page":"55","volume":"21","author":"M Kowalska","year":"2014","unstructured":"Kowalska, M., Niewiadomska, E. & Zejda, J. E. Epidemiology of sarcoidosis recorded in 2006\u20132010 in the Silesian voivodeship on the basis of routine medical reporting. Ann. Agric. Environ. Med. 21, 55\u201358 (2014).","journal-title":"Ann. Agric. Environ. Med."},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1183\/09031936.00197808","volume":"35","author":"U Deubelbeiss","year":"2010","unstructured":"Deubelbeiss, U., Gemperli, A., Schindler, C., Baty, F. & Brutsche, M. H. Prevalence of sarcoidosis in Switzerland is associated with environmental factors. Eur. Respir. J. 35, 1088\u20131097 (2010).","journal-title":"Eur. Respir. J."},{"key":"96_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2040622318790197","volume":"9","author":"EV Arkema","year":"2018","unstructured":"Arkema, E. V. & Cozier, Y. C. Epidemiology of sarcoidosis: current findings and future directions. Ther. Adv. Chronic Dis. 9, 227\u2013240 (2018).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"96_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.04.00070503","volume":"24","author":"DL Rabin","year":"2004","unstructured":"Rabin, D. L. et al. Sarcoidosis: social predictors of severity at presentation. Eur. Respir. J. 24, 601\u2013608 (2004).","journal-title":"Eur. Respir. J."},{"key":"96_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1183\/09031936.01.00056201","volume":"18","author":"DL Rabin","year":"2001","unstructured":"Rabin, D. L., Richardson, M. S., Stein, S. R. & Yeager, H. Jr Sarcoidosis severity and socioeconomic status. Eur. Respir. J. 18, 499\u2013506 (2001).","journal-title":"Eur. Respir. J."},{"key":"96_CR19","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman, R. P. et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am. J. Respir. Crit. Care Med. 164, 1885\u20131889 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","volume":"179","author":"J Grunewald","year":"2009","unstructured":"Grunewald, J. & Eklund, A. Lofgren\u2019s syndrome: human leukocyte antigen strongly influences the disease course. Am. J. Respir. Crit. Care Med. 179, 307\u2013312 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.201507-1372OC","volume":"193","author":"NV Rivera","year":"2016","unstructured":"Rivera, N. V. et al. High-density genetic mapping identifies new susceptibility variants in sarcoidosis phenotypes and shows genomic-driven phenotypic differences. Am. J. Respir. Crit. Care Med. 193, 1008\u20131022 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/ajrccm.164.5.2007056","volume":"164","author":"M Schurmann","year":"2001","unstructured":"Schurmann, M. et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit. Care Med. 164, 840\u2013846 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12016-015-8477-8","volume":"49","author":"J Grunewald","year":"2015","unstructured":"Grunewald, J., Spagnolo, P., Wahlstrom, J. & Eklund, A. Immunogenetics of disease-causing inflammation in sarcoidosis. Clin. Rev. Allergy Immunol. 49, 19\u201335 (2015).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"96_CR24","doi-asserted-by":"crossref","first-page":"1800385","DOI":"10.1183\/13993003.00385-2018","volume":"52","author":"M Rossides","year":"2018","unstructured":"Rossides, M. et al. Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study. Eur. Respir. J. 52, 1800385 (2018).","journal-title":"Eur. Respir. J."},{"key":"96_CR25","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","volume":"164","author":"BA Rybicki","year":"2001","unstructured":"Rybicki, B. A. et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am. J. Respir. Crit. Care Med. 164, 2085\u20132091 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2007.094060","volume":"63","author":"A Sverrild","year":"2008","unstructured":"Sverrild, A. et al. Heredity in sarcoidosis: a registry-based twin study. Thorax 63, 894\u2013896 (2008).","journal-title":"Thorax"},{"key":"96_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1749-6632.1976.tb47049.x","volume":"278","author":"VE Headings","year":"1976","unstructured":"Headings, V. E., Weston, D., Young, R. C. Jr & Hackney, R. L. Jr Familial sarcoidosis with multiple occurrences in eleven families: a possible mechanism of inheritance. Ann. NY Acad. Sci. 278, 377\u2013385 (1976).","journal-title":"Ann. NY Acad. Sci."},{"key":"96_CR28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","volume":"170","author":"LS Newman","year":"2004","unstructured":"Newman, L. S. et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am. J. Respir. Crit. Care Med. 170, 1324\u20131330 (2004).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016839","volume":"7","author":"P Vihlborg","year":"2017","unstructured":"Vihlborg, P., Bryngelsson, I. L., Andersson, L. & Graff, P. Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study. BMJ Open 7, e016839 (2017).","journal-title":"BMJ Open"},{"key":"96_CR30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/ajrccm\/148.4_Pt_1.974","volume":"148","author":"DG Kern","year":"1993","unstructured":"Kern, D. G., Neill, M. A., Wrenn, D. S. & Varone, J. C. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am. Rev. Respir. Dis. 148, 974\u2013980 (1993).","journal-title":"Am. Rev. Respir. Dis."},{"key":"96_CR31","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1378\/chest.116.5.1183","volume":"116","author":"DJ Prezant","year":"1999","unstructured":"Prezant, D. J. et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 116, 1183\u20131193 (1999).","journal-title":"Chest"},{"key":"96_CR32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajim.20924","volume":"54","author":"LE Crowley","year":"2011","unstructured":"Crowley, L. E. et al. \u201cSarcoid like\u201d granulomatous pulmonary disease in World Trade Center disaster responders. Am. J. Ind. Med. 54, 175\u2013184 (2011).","journal-title":"Am. J. Ind. Med."},{"key":"96_CR33","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.06-2114","volume":"131","author":"G Izbicki","year":"2007","unstructured":"Izbicki, G. et al. World Trade Center \u201csarcoid-like\u201d granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131, 1414\u20131423 (2007).","journal-title":"Chest"},{"key":"96_CR34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/JOM.0b013e31822a3596","volume":"53","author":"HT Jordan","year":"2011","unstructured":"Jordan, H. T. et al. Sarcoidosis diagnosed after September 11, 2001, among adults exposed to the World Trade Center disaster. J. Occup. Environ. Med. 53, 966\u2013974 (2011).","journal-title":"J. Occup. Environ. Med."},{"key":"96_CR35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","volume":"16","author":"T Esteves","year":"2016","unstructured":"Esteves, T., Aparicio, G. & Garcia-Patos, V. Is there any association between Sarcoidosis and infectious agents? A systematic review and meta-analysis. BMC Pulm. Med. 16, 165 (2016).","journal-title":"BMC Pulm. Med."},{"key":"96_CR36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.200909-1338OC","volume":"181","author":"C Carlens","year":"2010","unstructured":"Carlens, C. et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am. J. Respir. Crit. Care Med. 181, 1217\u20131222 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rmed.2016.10.003","volume":"120","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert, P., Crowson, C. S. & Matteson, E. L. Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study. Respir. Med. 120, 87\u201390 (2016).","journal-title":"Respir. Med."},{"key":"96_CR38","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/thx.43.7.516","volume":"43","author":"D Valeyre","year":"1988","unstructured":"Valeyre, D. et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 43, 516\u2013524 (1988).","journal-title":"Thorax"},{"key":"96_CR39","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1378\/chest.14-1099","volume":"147","author":"YC Cozier","year":"2015","unstructured":"Cozier, Y. C. et al. Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women\u2019s Health Study. Chest 147, 1086\u20131093 (2015).","journal-title":"Chest"},{"key":"96_CR40","doi-asserted-by":"crossref","first-page":"1701397","DOI":"10.1183\/13993003.01397-2017","volume":"50","author":"O Dumas","year":"2017","unstructured":"Dumas, O., Boggs, K. M., Cozier, Y. C., Stampfer, M. J. & Camargo, C. A. Jr Prospective study of body mass index and risk of sarcoidosis in US women. Eur. Respir. J. 50, 1701397 (2017).","journal-title":"Eur. Respir. J."},{"key":"96_CR41","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","volume":"13","author":"M Versini","year":"2014","unstructured":"Versini, M., Jeandel, P. Y., Rosenthal, E. & Shoenfeld, Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun. Rev. 13, 981\u20131000 (2014).","journal-title":"Autoimmun. Rev."},{"key":"96_CR42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/aje\/kws145","volume":"176","author":"YC Cozier","year":"2012","unstructured":"Cozier, Y. C. et al. Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: the Black Women\u2019s Health Study. Am. J. Epidemiol. 176, 635\u2013641 (2012).","journal-title":"Am. J. Epidemiol."},{"key":"96_CR43","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","volume":"14","author":"AK Gerke","year":"2017","unstructured":"Gerke, A. K., Judson, M. A., Cozier, Y. C., Culver, D. A. & Koth, L. L. Disease burden and variability in sarcoidosis. Ann. Am. Thorac. Soc. 14, S421\u2013S428 (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"96_CR44","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thx.2006.062836","volume":"61","author":"J Gribbin","year":"2006","unstructured":"Gribbin, J. et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61, 980\u2013985 (2006).","journal-title":"Thorax"},{"key":"96_CR45","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.rmed.2018.03.028","volume":"144S","author":"JE Park","year":"2018","unstructured":"Park, J. E. et al. Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003-2015: A nationwide population-based study. Respir. Med. 144S, S28\u2013S34 (2018).","journal-title":"Respir. Med."},{"key":"96_CR46","doi-asserted-by":"crossref","first-page":"1701815","DOI":"10.1183\/13993003.01815-2017","volume":"51","author":"M Rossides","year":"2018","unstructured":"Rossides, M. et al. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur. Respir. J. 51, 1701815 (2018).","journal-title":"Eur. Respir. J."},{"key":"96_CR47","first-page":"128","volume":"30","author":"MH Tukey","year":"2013","unstructured":"Tukey, M. H. et al. Mortality among African American women with sarcoidosis: data from the Black Women\u2019s Health Study. Sarcoidosis Vasc. Diffuse Lung Dis. 30, 128\u2013133 (2013).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","volume":"91","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert, P. et al. Epidemiology of sarcoidosis 1946-2013: a population-based study. Mayo Clin. Proc. 91, 183\u2013188 (2016).","journal-title":"Mayo Clin. Proc."},{"key":"96_CR49","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","volume":"38","author":"A Nardi","year":"2011","unstructured":"Nardi, A. et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur. Respir. J. 38, 1368\u20131373 (2011).","journal-title":"Eur. Respir. J."},{"key":"96_CR50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1513\/AnnalsATS.201610-750OC","volume":"14","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert, P., Crowson, C. S. & Matteson, E. L. Sarcoidosis increases risk of hospitalized infection. A population-based study, 1976\u20132013. Ann. Am. Thorac. Soc. 14, 676\u2013681 (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"96_CR51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2010.134429","volume":"66","author":"AP Crawshaw","year":"2011","unstructured":"Crawshaw, A. P., Wotton, C. J., Yeates, D. G., Goldacre, M. J. & Ho, L. P. Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study. Thorax 66, 447\u2013448 (2011).","journal-title":"Thorax"},{"key":"96_CR52","doi-asserted-by":"crossref","first-page":"1601290","DOI":"10.1183\/13993003.01290-2016","volume":"49","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert, P., Crowson, C. S. & Matteson, E. L. Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976\u20132013. Eur. Respir. J. 49, 1601290 (2017).","journal-title":"Eur. Respir. J."},{"key":"96_CR53","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.chest.2017.03.022","volume":"151","author":"ZJ Yaqoob","year":"2017","unstructured":"Yaqoob, Z. J., Al-Kindi, S. G. & Zein, J. G. Sarcoidosis and risk of VTE: validation with big data. Chest 151, 1398\u20131399 (2017).","journal-title":"Chest"},{"key":"96_CR54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chest.2016.09.009","volume":"151","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert, P., Crowson, C. S. & Matteson, E. L. Association of sarcoidosis with increased risk of VTE: a population-based study, 1976 to 2013. Chest 151, 425\u2013430 (2017).","journal-title":"Chest"},{"key":"96_CR55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1346-8138.13654","volume":"44","author":"CH Wu","year":"2017","unstructured":"Wu, C. H. et al. Comorbid autoimmune diseases in patients with sarcoidosis: a nationwide case-control study in Taiwan. J. Dermatol. 44, 423\u2013430 (2017).","journal-title":"J. Dermatol."},{"key":"96_CR56","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1378\/chest.14-1475","volume":"147","author":"M Bonifazi","year":"2015","unstructured":"Bonifazi, M. et al. Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. Chest 147, 778\u2013791 (2015).","journal-title":"Chest"},{"key":"96_CR57","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake, G. W. et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 16, 149\u2013173 (1999).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","volume":"66","author":"M Facco","year":"2011","unstructured":"Facco, M. et al. Sarcoidosis is a Th1\/Th17 multisystem disorder. Thorax 66, 144\u2013150 (2011).","journal-title":"Thorax"},{"key":"96_CR59","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","volume":"193","author":"J Ramstein","year":"2016","unstructured":"Ramstein, J. et al. Interferon-gamma-producing Th17.1 Cells are increased in sarcoidosis and more prevalent than Th1 cells. Am. J. Respir. Crit. Care Med. 193, 1281\u20131291 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR60","doi-asserted-by":"crossref","first-page":"1701124","DOI":"10.1183\/13993003.01124-2017","volume":"51","author":"CE Broos","year":"2018","unstructured":"Broos, C. E. et al. Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes. Eur. Respir. J. 51, 1701124 (2018).","journal-title":"Eur. Respir. J."},{"key":"96_CR61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2017.12.012","volume":"87","author":"JR Miedema","year":"2018","unstructured":"Miedema, J. R. et al. Th17-lineage cells in pulmonary sarcoidosis and Lofgren\u2019s syndrome: friend or foe? J. Autoimmun. 87, 82\u201396 (2018).","journal-title":"J. Autoimmun."},{"key":"96_CR62","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12403","volume":"178","author":"M Ostadkarampour","year":"2014","unstructured":"Ostadkarampour, M. et al. Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren\u2019s syndrome. Clin. Exp. Immunol. 178, 342\u2013352 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"96_CR63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1183\/13993003.00092-2016","volume":"48","author":"Y Kaiser","year":"2016","unstructured":"Kaiser, Y. et al. Expanded lung T-bet+RORgammaT+ CD4+ T cells in sarcoidosis patients with a favourable disease phenotype. Eur. Respir. J. 48, 484\u2013494 (2016).","journal-title":"Eur. Respir. J."},{"key":"96_CR64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","volume":"203","author":"M Miyara","year":"2006","unstructured":"Miyara, M. et al. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203, 359\u2013370 (2006).","journal-title":"J. Exp. Med."},{"key":"96_CR65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2353\/ajpath.2009.080580","volume":"174","author":"C Taflin","year":"2009","unstructured":"Taflin, C. et al. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am. J. Pathol. 174, 497\u2013508 (2009).","journal-title":"Am. J. Pathol."},{"key":"96_CR66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.200909-1451OC","volume":"182","author":"A Prasse","year":"2010","unstructured":"Prasse, A. et al. Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. Am. J. Respir. Crit. Care Med. 182, 540\u2013548 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.gene.2016.09.037","volume":"596","author":"H Li","year":"2017","unstructured":"Li, H., Zhao, X., Wang, J., Zong, M. & Yang, H. Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis. Gene 596, 98\u2013104 (2017).","journal-title":"Gene"},{"key":"96_CR68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","volume":"132","author":"JT Rosenbaum","year":"2009","unstructured":"Rosenbaum, J. T. et al. Hypothesis: sarcoidosis is a STAT1-mediated disease. Clin. Immunol. 132, 174\u2013183 (2009).","journal-title":"Clin. Immunol."},{"key":"96_CR69","volume":"7","author":"T Zhou","year":"2017","unstructured":"Zhou, T. et al. Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature. Sci. Rep. 7, 4237 (2017).","journal-title":"Sci. Rep."},{"key":"96_CR70","volume":"7","author":"T Zhou","year":"2012","unstructured":"Zhou, T. et al. Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PLOS ONE 7, e44818 (2012).","journal-title":"PLOS ONE"},{"key":"96_CR71","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar8356","volume":"10","author":"LJ Celada","year":"2018","unstructured":"Celada, L. J. et al. PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production. Sci. Transl Med. 10, eaar8356 (2018).","journal-title":"Sci. Transl Med."},{"key":"96_CR72","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","volume":"379","author":"W Damsky","year":"2018","unstructured":"Damsky, W., Thakral, D., Emeagwali, N., Galan, A. & King, B. Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis. N. Engl. J. Med. 379, 2540\u20132546 (2018).","journal-title":"N. Engl. J. Med."},{"key":"96_CR73","doi-asserted-by":"crossref","first-page":"1801482","DOI":"10.1183\/13993003.01482-2018","volume":"52","author":"C Rotenberg","year":"2018","unstructured":"Rotenberg, C. et al. Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia. Eur. Respir. J. 52, 1801482 (2018).","journal-title":"Eur. Respir. J."},{"key":"96_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2018.01.005","volume":"129","author":"LE Vega","year":"2018","unstructured":"Vega, L. E. & Espinoza, L. R. HIV infection and its effects on the development of autoimmune disorders. Pharmacol. Res. 129, 1\u20139 (2018).","journal-title":"Pharmacol. Res."},{"key":"96_CR75","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/381094","volume":"38","author":"G Foulon","year":"2004","unstructured":"Foulon, G. et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 38, 418\u2013425 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"96_CR76","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1378\/chest.124.3.929","volume":"124","author":"DG Morris","year":"2003","unstructured":"Morris, D. G. et al. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest 124, 929\u2013935 (2003).","journal-title":"Chest"},{"key":"96_CR77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","volume":"18","author":"M Linke","year":"2017","unstructured":"Linke, M. et al. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression. Nat. Immunol. 18, 293\u2013302 (2017).","journal-title":"Nat. Immunol."},{"key":"96_CR78","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.humimm.2013.08.275","volume":"74","author":"A Dubaniewicz","year":"2013","unstructured":"Dubaniewicz, A. Microbial and human heat shock proteins as \u2018danger signals\u2019 in sarcoidosis. Hum. Immunol. 74, 1550\u20131558 (2013).","journal-title":"Hum. Immunol."},{"key":"96_CR79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10875-008-9225-0","volume":"29","author":"M Wiken","year":"2009","unstructured":"Wiken, M., Grunewald, J., Eklund, A. & Wahlstrom, J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J. Clin. Immunol. 29, 78\u201389 (2009).","journal-title":"J. Clin. Immunol."},{"key":"96_CR80","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1465-9921-11-121","volume":"11","author":"M Wiken","year":"2010","unstructured":"Wiken, M. et al. No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Respir. Res. 11, 121 (2010).","journal-title":"Respir. Res."},{"key":"96_CR81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrrheum.2011.93","volume":"7","author":"ES Chen","year":"2011","unstructured":"Chen, E. S. & Moller, D. R. Sarcoidosis\u2014scientific progress and clinical challenges. Nat. Rev. Rheumatol. 7, 457\u2013467 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"96_CR82","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","volume":"181","author":"ES Chen","year":"2010","unstructured":"Chen, E. S. et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am. J. Respir. Crit. Care Med. 181, 360\u2013373 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR83","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/ajrccm.163.7.2005028","volume":"163","author":"K Katchar","year":"2001","unstructured":"Katchar, K., Wahlstrom, J., Eklund, A. & Grunewald, J. Highly activated T cell receptor AV2S3+ CD4+ lung T cell expansions in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 163, 1540\u20131545 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR84","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1164\/ajrccm\/140.1.82","volume":"140","author":"J Muller-Quernheim","year":"1989","unstructured":"Muller-Quernheim, J., Kronke, M., Strausz, J., Schykowski, M. & Ferlinz, R. Interleukin-2 receptor gene expression by bronchoalveolar lavage lymphocytes in pulmonary sarcoidosis. Am. Rev. Respir. Dis. 140, 82\u201388 (1989).","journal-title":"Am. Rev. Respir. Dis."},{"key":"96_CR85","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0037-1602380","volume":"38","author":"B Karakaya","year":"2017","unstructured":"Karakaya, B., Kaiser, Y., van Moorsel, C. H. M. & Grunewald, J. Lofgren\u2019s syndrome: diagnosis, management, and disease pathogenesis. Semin. Respir. Crit. Care Med. 38, 463\u2013476 (2017).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"96_CR86","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/cei.12715","volume":"183","author":"P Sakthivel","year":"2015","unstructured":"Sakthivel, P., Grunewald, J., Eklund, A., Bruder, D. & Wahlstrom, J. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells\u2013possible implications for the ICOS\/ICOS-ligand axis in disease course and resolution. Clin. Exp. Immunol. 183, 294\u2013306 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"96_CR87","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1183\/09031936.06.00067105","volume":"27","author":"F Idali","year":"2006","unstructured":"Idali, F. et al. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur. Respir. J. 27, 451\u2013459 (2006).","journal-title":"Eur. Respir. J."},{"key":"96_CR88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1465-9921-10-42","volume":"10","author":"F Idali","year":"2009","unstructured":"Idali, F. et al. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir. Res. 10, 42 (2009).","journal-title":"Respir. Res."},{"key":"96_CR89","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccm.2008.03.011","volume":"29","author":"ES Chen","year":"2008","unstructured":"Chen, E. S. & Moller, D. R. Etiology of sarcoidosis. Clin. Chest Med. 29, 365\u2013377 (2008).","journal-title":"Clin. Chest Med."},{"key":"96_CR90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.1830220120","volume":"22","author":"J Grunewald","year":"1992","unstructured":"Grunewald, J. et al. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur. J. Immunol. 22, 129\u2013135 (1992).","journal-title":"Eur. J. Immunol."},{"key":"96_CR91","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI113715","volume":"82","author":"DR Moller","year":"1988","unstructured":"Moller, D. R., Konishi, K., Kirby, M., Balbi, B. & Crystal, R. G. Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis. J. Clin. Invest. 82, 1183\u20131191 (1988).","journal-title":"J. Clin. Invest."},{"key":"96_CR92","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1073\/pnas.91.11.4965","volume":"91","author":"J Grunewald","year":"1994","unstructured":"Grunewald, J. et al. T cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc. Natl Acad. Sci. USA 91, 4965\u20134969 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"96_CR93","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/ajrccm.161.3.9906001","volume":"161","author":"J Grunewald","year":"2000","unstructured":"Grunewald, J., Berlin, M., Olerup, O. & Eklund, A. Lung T-helper cells expressing T cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 161, 814\u2013818 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR94","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2466-14-50","volume":"14","author":"KM Ahlgren","year":"2014","unstructured":"Ahlgren, K. M., Ruckdeschel, T., Eklund, A., Wahlstrom, J. & Grunewald, J. T cell receptor-Vbeta repertoires in lung and blood CD4+ and CD8+ T cells of pulmonary sarcoidosis patients. BMC Pulm. Med. 14, 50 (2014).","journal-title":"BMC Pulm. Med."},{"key":"96_CR95","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1183\/13993003.01209-2015","volume":"47","author":"J Grunewald","year":"2016","unstructured":"Grunewald, J. et al. T cell receptor-HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis. Eur. Respir. J. 47, 898\u2013909 (2016).","journal-title":"Eur. Respir. J."},{"key":"96_CR96","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4049\/jimmunol.1700570","volume":"199","author":"AM Mitchell","year":"2017","unstructured":"Mitchell, A. M. et al. Shared alphabeta TCR usage in lungs of sarcoidosis patients with Lofgren\u2019s syndrome. J. Immunol. 199, 2279\u20132290 (2017).","journal-title":"J. Immunol."},{"key":"96_CR97","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1468-1331.2001.00229.x","volume":"8","author":"JG Heckmann","year":"2001","unstructured":"Heckmann, J. G., Stefan, H., Heuss, D., Hopp, P. & Neundorfer, B. Isolated muscular sarcoidosis. Eur. J. Neurol. 8, 365\u2013366 (2001).","journal-title":"Eur. J. Neurol."},{"key":"96_CR98","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1074\/mcp.M116.060764","volume":"15","author":"T Heyder","year":"2016","unstructured":"Heyder, T. et al. Approach for identifying human leukocyte antigen (HLA)-DR bound peptides from scarce clinical samples. Mol. Cell. Proteomics 15, 3017\u20133029 (2016).","journal-title":"Mol. Cell. Proteomics"},{"key":"96_CR99","first-page":"169","volume":"9","author":"A Kveim","year":"1941","unstructured":"Kveim, A. A new and specific cutaneous reaction in Boeck\u2019s sarcoid [Norwegian]. Nord. Med. 9, 169 (1941).","journal-title":"Nord. Med."},{"key":"96_CR100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jama.1961.03040440028006","volume":"178","author":"L Siltzbach","year":"1961","unstructured":"Siltzbach, L. The Kveim test in sarcoidosis: a study of 750 patients. JAMA 178, 476\u2013482 (1961).","journal-title":"JAMA"},{"key":"96_CR101","first-page":"86","volume":"84","author":"M Chase","year":"1961","unstructured":"Chase, M. The preparation and standardization of Kveim testing antigen. Am. Rev. Respir. Dis. 84, 86\u201388 (1961).","journal-title":"Am. Rev. Respir. Dis."},{"key":"96_CR102","volume":"12","author":"C Eberhardt","year":"2017","unstructured":"Eberhardt, C. et al. Proteomic analysis of Kveim reagent identifies targets of cellular immunity in sarcoidosis. PLOS ONE 12, e0170285 (2017).","journal-title":"PLOS ONE"},{"key":"96_CR103","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.4049\/jimmunol.154.3.1450","volume":"154","author":"JT Klein","year":"1995","unstructured":"Klein, J. T. et al. Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J. Immunol. 154, 1450\u20131460 (1995).","journal-title":"J. Immunol."},{"key":"96_CR104","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ncb0804-699","volume":"6","author":"PA Coulombe","year":"2004","unstructured":"Coulombe, P. A. & Wong, P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat. Cell Biol. 6, 699\u2013706 (2004).","journal-title":"Nat. Cell Biol."},{"key":"96_CR105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ncb898","volume":"5","author":"N Mor-Vaknin","year":"2003","unstructured":"Mor-Vaknin, N., Punturieri, A., Sitwala, K. & Markovitz, D. M. Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5, 59\u201363 (2003).","journal-title":"Nat. Cell Biol."},{"key":"96_CR106","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1172\/JCI32401","volume":"117","author":"J Wahlstrom","year":"2007","unstructured":"Wahlstrom, J. et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J. Clin. Invest. 117, 3576\u20133582 (2007).","journal-title":"J. Clin. Invest."},{"key":"96_CR107","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clim.2009.08.008","volume":"133","author":"J Wahlstrom","year":"2009","unstructured":"Wahlstrom, J. et al. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin. Immunol. 133, 353\u2013363 (2009).","journal-title":"Clin. Immunol."},{"key":"96_CR108","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","volume":"9","author":"AJ Kinloch","year":"2018","unstructured":"Kinloch, A. J. et al. In situ humoral immunity to vimentin in HLA-DRB1*03+ patients with pulmonary sarcoidosis. Front. Immunol. 9, 1516 (2018).","journal-title":"Front. Immunol."},{"key":"96_CR109","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","volume":"233","author":"N Wegner","year":"2010","unstructured":"Wegner, N. et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34\u201354 (2010).","journal-title":"Immunol. Rev."},{"key":"96_CR110","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1002\/art.38888","volume":"66","author":"AJ Kinloch","year":"2014","unstructured":"Kinloch, A. J. et al. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol. 66, 3359\u20133370 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"96_CR111","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.021532018","author":"Y Kaiser","year":"2019","unstructured":"Kaiser, Y., Eklund, A. & Grunewald, J. Moving target \u2014 shifting the focus to pulmonary sarcoidosis as an autoimmune spectrum disorder. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.021532018 (2019).","journal-title":"Eur. Respir. J."},{"key":"96_CR112","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jfma.2014.07.008","volume":"113","author":"CH Chiang","year":"2014","unstructured":"Chiang, C. H. & Lai, F. J. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C. J. Formos. Med. Assoc. 113, 981\u2013982 (2014).","journal-title":"J. Formos. Med. Assoc."},{"key":"96_CR113","first-page":"e347","volume":"12","author":"EK Jeon","year":"2016","unstructured":"Jeon, E. K. et al. First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma. Asia Pac. J. Clin. Oncol. 12, e347\u2013e349 (2016).","journal-title":"J. Clin. Oncol."},{"key":"96_CR114","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1111\/ijd.12676","volume":"54","author":"AC Viana de Andrade","year":"2015","unstructured":"Viana de Andrade, A. C. et al. Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: case report. Int. J. Dermatol. 54, e140\u2013e145 (2015).","journal-title":"Int. J. Dermatol."},{"key":"96_CR115","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1200\/JCO.2011.39.3298","volume":"30","author":"G Berthod","year":"2012","unstructured":"Berthod, G. et al. Pulmonary sarcoid-like granulomatosis induced by ipilimumab. J. Clin. Oncol. 30, e156\u2013e159 (2012).","journal-title":"J. Clin. Oncol."},{"key":"96_CR116","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ctrv.2016.02.001","volume":"44","author":"L Spain","year":"2016","unstructured":"Spain, L., Diem, S. & Larkin, J. Management of toxicities of immune checkpoint inhibitors. Cancer Treat. Rev. 44, 51\u201360 (2016).","journal-title":"Cancer Treat. Rev."},{"key":"96_CR117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160221","volume":"11","author":"N Abdel-Wahab","year":"2016","unstructured":"Abdel-Wahab, N., Shah, M. & Suarez-Almazor, M. E. Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports. PLOS ONE 11, e0160221 (2016).","journal-title":"PLOS ONE"},{"key":"96_CR118","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","volume":"154","author":"A Chopra","year":"2018","unstructured":"Chopra, A., Nautiyal, A., Kalkanis, A. & Judson, M. A. Drug-induced sarcoidosis-like reactions. Chest 154, 664\u2013677 (2018).","journal-title":"Chest"},{"key":"96_CR119","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201503-0635LE","volume":"192","author":"CE Broos","year":"2015","unstructured":"Broos, C. E. et al. Decreased cytotoxic T-lymphocyte antigen 4 expression on regulatory T cells and Th17 cells in sarcoidosis: double trouble? Am. J. Respir. Crit. Care Med. 192, 763\u2013765 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2016-0037OC","volume":"56","author":"LJ Celada","year":"2017","unstructured":"Celada, L. J. et al. Programmed death-1 inhibition of phosphatidylinositol 3-kinase\/AKT\/mechanistic target of rapamycin signaling impairs sarcoidosis CD4+ T cell proliferation. Am. J. Respir. Cell. Mol. Biol. 56, 74\u201382 (2017).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"96_CR121","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.4049\/jimmunol.180.4.2704","volume":"180","author":"BE Palmer","year":"2008","unstructured":"Palmer, B. E. et al. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease. J. Immunol. 180, 2704\u20132712 (2008).","journal-title":"J. Immunol."},{"key":"96_CR122","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.4049\/jimmunol.181.6.4381","volume":"181","author":"DG Mack","year":"2008","unstructured":"Mack, D. G. et al. 4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease. J. Immunol. 181, 4381\u20134388 (2008).","journal-title":"J. Immunol."},{"key":"96_CR123","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdcr.2017.02.015","volume":"3","author":"MR Birnbaum","year":"2017","unstructured":"Birnbaum, M. R. et al. Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma. JAAD Case Rep. 3, 208\u2013211 (2017).","journal-title":"JAAD Case Rep."},{"key":"96_CR124","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","volume":"149","author":"FX Danlos","year":"2016","unstructured":"Danlos, F. X. et al. Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma. Chest 149, e133\u2013e136 (2016).","journal-title":"Chest"},{"key":"96_CR125","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.14808","volume":"176","author":"H Montaudie","year":"2017","unstructured":"Montaudie, H., Pradelli, J., Passeron, T., Lacour, J. P. & Leroy, S. Pulmonary sarcoid-like granulomatosis induced by nivolumab. Br. J. Dermatol. 176, 1060\u20131063 (2017).","journal-title":"Br. J. Dermatol."},{"key":"96_CR126","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdcr.2016.05.002","volume":"2","author":"KC Suozzi","year":"2016","unstructured":"Suozzi, K. C. et al. Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy. JAAD Case Rep. 2, 264\u2013268 (2016).","journal-title":"JAAD Case Rep."},{"key":"96_CR127","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1200\/JCO.2011.37.9693","volume":"30","author":"WV Vogel","year":"2012","unstructured":"Vogel, W. V. et al. Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission. J. Clin. Oncol. 30, e7\u2013e10 (2012).","journal-title":"J. Clin. Oncol."},{"key":"96_CR128","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","volume":"379","author":"E Marijon","year":"2012","unstructured":"Marijon, E., Mirabel, M., Celermajer, D. S. & Jouven, X. Rheumatic heart disease. Lancet 379, 953\u2013964 (2012).","journal-title":"Lancet"},{"key":"96_CR129","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1742-1241.2006.00773.x","volume":"60","author":"SS Demirkok","year":"2006","unstructured":"Demirkok, S. S., Basaranoglu, M. & Akbilgic, O. Seasonal variation of the onset of presentations in stage 1 sarcoidosis. Int. J. Clin. Pract. 60, 1443\u20131450 (2006).","journal-title":"Int. J. Clin. Pract."},{"key":"96_CR130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/34.1.45","volume":"34","author":"A Glennas","year":"1995","unstructured":"Glennas, A. et al. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br. J. Rheumatol. 34, 45\u201350 (1995).","journal-title":"Br. J. Rheumatol."},{"key":"96_CR131","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1183\/09031936.98.12051197","volume":"12","author":"ML Wilsher","year":"1998","unstructured":"Wilsher, M. L. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur. Respir. J. 12, 1197\u20131199 (1998).","journal-title":"Eur. Respir. J."},{"key":"96_CR132","first-page":"161","volume":"14","author":"A Heyll","year":"1994","unstructured":"Heyll, A. et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant. 14, 161\u2013164 (1994).","journal-title":"Bone Marrow Transplant."},{"key":"96_CR133","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1183\/09031936.00002607","volume":"30","author":"D Gupta","year":"2007","unstructured":"Gupta, D., Agarwal, R., Aggarwal, A. N. & Jindal, S. K. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur. Respir. J. 30, 508\u2013516 (2007).","journal-title":"Eur. Respir. J."},{"key":"96_CR134","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.4049\/jimmunol.181.12.8784","volume":"181","author":"ES Chen","year":"2008","unstructured":"Chen, E. S. et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J. Immunol. 181, 8784\u20138796 (2008).","journal-title":"J. Immunol."},{"key":"96_CR135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20040429","volume":"201","author":"Z Song","year":"2005","unstructured":"Song, Z. et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201, 755\u2013767 (2005).","journal-title":"J. Exp. Med."},{"key":"96_CR136","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/IAI.00732-06","volume":"75","author":"WP Drake","year":"2007","unstructured":"Drake, W. P. et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect. Immun. 75, 527\u2013530 (2007).","journal-title":"Infect. Immun."},{"key":"96_CR137","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10875-009-9311-y","volume":"30","author":"K Oswald-Richter","year":"2009","unstructured":"Oswald-Richter, K. et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. J. Clin. Immunol. 30, 157\u2013166 (2009).","journal-title":"J. Clin. Immunol."},{"key":"96_CR138","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","volume":"40","author":"Y Eishi","year":"2002","unstructured":"Eishi, Y. et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J. Clin. Microbiol. 40, 198\u2013204 (2002).","journal-title":"J. Clin. Microbiol."},{"key":"96_CR139","first-page":"33","volume":"22","author":"I Ishige","year":"2005","unstructured":"Ishige, I. et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 22, 33\u201342 (2005).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2016-1070","volume":"37","author":"PJ Tebben","year":"2016","unstructured":"Tebben, P. J., Singh, R. J. & Kumar, R. Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr. Rev. 37, 521\u2013547 (2016).","journal-title":"Endocr. Rev."},{"key":"96_CR141","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpsychores.2011.10.001","volume":"72","author":"IH Korenromp","year":"2012","unstructured":"Korenromp, I. H., Grutters, J. C., van den Bosch, J. M. & Heijnen, C. J. Post-inflammatory fatigue in sarcoidosis: personality profiles, psychological symptoms and stress hormones. J. Psychosom. Res. 72, 97\u2013102 (2012).","journal-title":"J. Psychosom. Res."},{"key":"96_CR142","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbi.2013.05.006","volume":"33","author":"AW Braam","year":"2013","unstructured":"Braam, A. W. et al. Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis. Brain Behav. Immun. 33, 57\u201364 (2013).","journal-title":"Brain Behav. Immun."},{"key":"96_CR143","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbi.2011.06.004","volume":"25","author":"IH Korenromp","year":"2011","unstructured":"Korenromp, I. H. et al. Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue. Brain Behav. Immun. 25, 1498\u20131502 (2011).","journal-title":"Brain Behav. Immun."},{"key":"96_CR144","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1378\/chest.10-2629","volume":"140","author":"IHE Korenromp","year":"2011","unstructured":"Korenromp, I. H. E., Heijnen, C. J., Vogels, O. J. M., van den Bosch, J. M. M. & Grutters, J. C. Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest 140, 441\u2013447 (2011).","journal-title":"Chest"},{"key":"96_CR145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rmed.2016.05.010","volume":"116","author":"B Strookappe","year":"2016","unstructured":"Strookappe, B. et al. Predictors of fatigue in sarcoidosis: the value of exercise testing. Respir. Med. 116, 49\u201354 (2016).","journal-title":"Respir. Med."},{"key":"96_CR146","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre, D. et al. Sarcoidosis. Lancet 383, 1155\u20131167 (2014).","journal-title":"Lancet"},{"key":"96_CR147","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2018.10.004","volume":"144S","author":"AU Wells","year":"2018","unstructured":"Wells, A. U. Sarcoidosis: a benign disease or a culture of neglect? Respir. Med. 144S, S1\u2013S2 (2018).","journal-title":"Respir. Med."},{"key":"96_CR148","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF02008817","volume":"70","author":"C Heerfordt","year":"1909","unstructured":"Heerfordt, C. Uber eine febris uveo-parotidea subchronica. Albrecht Von Graefes Arch. Ophthalmol. 70, 254\u2013258 (1909).","journal-title":"Albrecht Von Graefes Arch. Ophthalmol."},{"key":"96_CR149","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/bmj.1.4656.745","volume":"1","author":"JG Scadding","year":"1950","unstructured":"Scadding, J. G. Sarcoidosis, with special reference to lung changes. Br. Med. J. 1, 745\u2013753 (1950).","journal-title":"Br. Med. J."},{"key":"96_CR150","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding, J. G. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation. Br. Med. J. 2, 1165\u20131172 (1961).","journal-title":"Br. Med. J."},{"key":"96_CR151","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","volume":"174","author":"M Abehsera","year":"2000","unstructured":"Abehsera, M. et al. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. Am. J. Roentgenol. 174, 1751\u20131757 (2000).","journal-title":"Am. J. Roentgenol."},{"key":"96_CR152","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","volume":"51","author":"JC Schupp","year":"2018","unstructured":"Schupp, J. C. et al. Phenotypes of organ involvement in sarcoidosis. Eur. Respir. J. 51, 1700991 (2018).","journal-title":"Eur. Respir. J."},{"key":"96_CR153","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0037-1602381","volume":"38","author":"DM Sayah","year":"2017","unstructured":"Sayah, D. M., Bradfield, J. S., Moriarty, J. M., Belperio, J. A. & Lynch, J. P. 3rd Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin. Respir. Crit. Care Med. 38, 477\u2013498 (2017).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"96_CR154","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie, D. H., Nery, P. B., Ha, A. C. & Beanlands, R. S. Cardiac sarcoidosis. J. Am. Coll. Cardiol. 68, 411\u2013421 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"96_CR155","first-page":"65","volume":"12","author":"EM Chau","year":"2006","unstructured":"Chau, E. M., Fan, K. Y. & Chow, W. H. Cardiac sarcoidosis: a potentially fatal but treatable form of infiltrative heart disease. Hong Kong Med. J. 12, 65\u201367 (2006).","journal-title":"Hong Kong Med. J."},{"key":"96_CR156","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0037-1604165","volume":"38","author":"DA Culver","year":"2017","unstructured":"Culver, D. A., Ribeiro Neto, M. L., Moss, B. P. & Willis, M. A. Neurosarcoidosis. Semin. Respir. Crit. Care Med. 38, 499\u2013513 (2017).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"96_CR157","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2169\/internalmedicine.43.960","volume":"43","author":"RP Tabuena","year":"2004","unstructured":"Tabuena, R. P. et al. Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. Intern. Med. 43, 960\u2013966 (2004).","journal-title":"Intern. Med."},{"key":"96_CR158","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","volume":"359","author":"E Hoitsma","year":"2002","unstructured":"Hoitsma, E. et al. Small fibre neuropathy in sarcoidosis. Lancet 359, 2085\u20132086 (2002).","journal-title":"Lancet"},{"key":"96_CR159","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/key316","volume":"58","author":"D Saygin","year":"2018","unstructured":"Saygin, D., Karunamurthy, A., English, J. & Aggarwal, R. Tattoo reaction as a presenting manifestation of systemic sarcoidosis. Rheumatology 58, 927 (2018).","journal-title":"Rheumatology"},{"key":"96_CR160","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.autrev.2016.09.009","volume":"15","author":"P Fallahi","year":"2016","unstructured":"Fallahi, P. et al. The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun. Rev. 15, 1125\u20131128 (2016).","journal-title":"Autoimmun. Rev."},{"key":"96_CR161","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","volume":"14","author":"U Costabel","year":"1999","unstructured":"Costabel, U. & Hunninghake, G. W. ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur. Respir. J. 14, 735\u2013737 (1999).","journal-title":"Eur. Respir. J."},{"key":"96_CR162","first-page":"325","volume":"13","author":"E Bargagli","year":"2018","unstructured":"Bargagli, E. & Prasse, A. Sarcoidosis: a review for the internist. Intern. Emerg. Med. 13, 325\u2013331 (2018).","journal-title":"Intern. Emerg. Med."},{"key":"96_CR163","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.chest.2018.02.003","volume":"154","author":"WE James","year":"2018","unstructured":"James, W. E. et al. Clinical features of extrapulmonary sarcoidosis without lung involvement. Chest 154, 349\u2013356 (2018).","journal-title":"Chest"},{"key":"96_CR164","first-page":"204","volume":"20","author":"MA Judson","year":"2003","unstructured":"Judson, M. A. et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc. Diffuse Lung Dis. 20, 204\u2013211 (2003).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1164\/ajrccm\/148.2.483","volume":"148","author":"S Gilbert","year":"1993","unstructured":"Gilbert, S., Steinbrech, D. S., Landas, S. K. & Hunninghake, G. W. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am.\u00a0Rev. Respir. Dis. 148, 483\u2013486 (1993).","journal-title":"Am. Rev. Respir. Dis."},{"key":"96_CR166","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.156.5.9704069","volume":"156","author":"M Berlin","year":"1997","unstructured":"Berlin, M., Fogdell-Hahn, A., Olerup, O., Eklund, A. & Grunewald, J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 156, 1601\u20131605 (1997).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR167","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1183\/13993003.01319-2015","volume":"47","author":"MP Huitema","year":"2016","unstructured":"Huitema, M. P. et al. Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis. Eur. Respir. J. 47, 673\u2013676 (2016).","journal-title":"Eur. Respir. J."},{"key":"96_CR168","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","volume":"2","author":"SL Walsh","year":"2014","unstructured":"Walsh, S. L. et al. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respir. Med. 2, 123\u2013130 (2014).","journal-title":"Lancet Respir. Med."},{"key":"96_CR169","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12350-012-9653-3","volume":"20","author":"M Soussan","year":"2013","unstructured":"Soussan, M. et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis. J. Nucl. Cardiol. 20, 120\u2013127 (2013).","journal-title":"J. Nucl. Cardiol."},{"key":"96_CR170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.00227014","volume":"46","author":"AD Vorselaars","year":"2015","unstructured":"Vorselaars, A. D. et al. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. Eur. Respir. J. 46, 175\u2013185 (2015).","journal-title":"Eur. Respir. J."},{"key":"96_CR171","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11936-018-0670-7","volume":"20","author":"Y Yatsynovich","year":"2018","unstructured":"Yatsynovich, Y. et al. Updates on the role of imaging in cardiac sarcoidosis. Curr. Treat. Opt. Cardiovasc. Med. 20, 74 (2018).","journal-title":"Curr. Treat. Opt. Cardiovasc. Med."},{"key":"96_CR172","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0034-1376866","volume":"35","author":"H Adams","year":"2014","unstructured":"Adams, H., Keijsers, R. G., Korenromp, I. H. & Grutters, J. C. FDG PET for gauging of sarcoid disease activity. Semin. Respir. Crit. Care Med. 35, 352\u2013361 (2014).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"96_CR173","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5578\/ttj.17.1.004","volume":"17","author":"T Goktalay","year":"2016","unstructured":"Goktalay, T. et al. The role of endobronchial biopsy in the diagnosis of pulmonary sarcoidosis. Turk. Thorac. J. 17, 22\u201327 (2016).","journal-title":"Turk. Thorac. J."},{"key":"96_CR174","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clim.2007.11.005","volume":"126","author":"M Heron","year":"2008","unstructured":"Heron, M. et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin. Immunol. 126, 338\u2013344 (2008).","journal-title":"Clin. Immunol."},{"key":"96_CR175","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000475843","volume":"94","author":"M Bonifazi","year":"2017","unstructured":"Bonifazi, M. et al. Conventional versus ultrasound-guided transbronchial needle aspiration for the diagnosis of hilar\/mediastinal lymph adenopathies: a randomized controlled trial. Respiration 94, 216\u2013223 (2017).","journal-title":"Respiration"},{"key":"96_CR176","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.2013.5823","volume":"309","author":"MB von Bartheld","year":"2013","unstructured":"von Bartheld, M. B. et al. Endosonography versus conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA 309, 2457\u20132464 (2013).","journal-title":"JAMA"},{"key":"96_CR177","first-page":"56","volume":"28","author":"RP Baughman","year":"2011","unstructured":"Baughman, R. P. et al. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc. Diffuse Lung Dis. 28, 56\u201364 (2011).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR178","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MCP.0000000000000077","volume":"20","author":"CA Pereira","year":"2014","unstructured":"Pereira, C. A., Dornfeld, M. C., Baughman, R. & Judson, M. A. Clinical phenotypes in sarcoidosis. Curr. Opin. Pulm. Med. 20, 496\u2013502 (2014).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"96_CR179","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","volume":"177","author":"A Prasse","year":"2008","unstructured":"Prasse, A. et al. Phenotyping sarcoidosis from a pulmonary perspective. Am. J. Respir. Crit. Care Med. 177, 330\u2013336 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/17512433.2018.1486706","volume":"11","author":"WE James","year":"2018","unstructured":"James, W. E. & Baughman, R. Treatment of sarcoidosis: grading the evidence. Expert Rev. Clin. Pharmacol. 11, 677\u2013687 (2018).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"96_CR181","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","volume":"104","author":"AC Schutt","year":"2010","unstructured":"Schutt, A. C., Bullington, W. M. & Judson, M. A. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir. Med. 104, 717\u2013723 (2010).","journal-title":"Respir. Med."},{"key":"96_CR182","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1479972316661926","volume":"14","author":"C Atkins","year":"2017","unstructured":"Atkins, C. & Wilson, A. M. Managing fatigue in sarcoidosis \u2014 a systematic review of the evidence. Chron. Respir. Dis. 14, 161\u2013173 (2017).","journal-title":"Chron. Respir. Dis."},{"key":"96_CR183","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1183\/09031936.93.05080997","volume":"5","author":"PN Dekhuijzen","year":"1992","unstructured":"Dekhuijzen, P. N. & Decramer, M. Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. Eur. Respir. J. 5, 997\u20131003 (1992).","journal-title":"Eur. Respir. J."},{"key":"96_CR184","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/17476348.2018.1480940","volume":"12","author":"T Schreiber","year":"2018","unstructured":"Schreiber, T. & Windisch, W. Respiratory muscle involvement in sarcoidosis. Expert Rev. Respir. Med. 12, 545\u2013548 (2018).","journal-title":"Expert Rev. Respir. Med."},{"key":"96_CR185","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11845-016-1539-y","volume":"186","author":"K O\u2019Connell","year":"2017","unstructured":"O\u2019Connell, K. et al. Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian population. Ir. J. Med. Sci. 186, 759\u2013766 (2017).","journal-title":"Ir. J. Med. Sci."},{"key":"96_CR186","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","volume":"227","author":"SK Padala","year":"2017","unstructured":"Padala, S. K., Peaslee, S., Sidhu, M. S., Steckman, D. A. & Judson, M. A. Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. Int. J. Cardiol. 227, 565\u2013570 (2017).","journal-title":"Int. J. Cardiol."},{"key":"96_CR187","first-page":"60","volume":"17","author":"RP Baughman","year":"2000","unstructured":"Baughman, R. P., Winget, D. B. & Lower, E. E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc. Diffuse Lung Dis. 17, 60\u201366 (2000).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR188","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1183\/09031936.99.14511179","volume":"14","author":"J M\u00fcller-Quernheim","year":"1999","unstructured":"M\u00fcller-Quernheim, J., Kienast, K., Held, M., Pfeifer, S. & Costabel, U. Treatment of chronic sarcoidosis with an azathioprine\/prednisolone regimen. Eur. Respir. J. 14, 1117\u20131122 (1999).","journal-title":"Eur. Respir. J."},{"key":"96_CR189","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/ajrccm.149.4.8143052","volume":"149","author":"GW Hunninghake","year":"1994","unstructured":"Hunninghake, G. W. et al. Outcome of the treatment of sarcoidosis. Am. J. Respir. Crit. Care Med. 149, 893\u2013898 (1994).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","volume":"51","author":"GJ Gibson","year":"1996","unstructured":"Gibson, G. J. et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 51, 238\u2013247 (1996).","journal-title":"Thorax"},{"key":"96_CR191","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1183\/09031936.99.13613459","volume":"13","author":"M Drent","year":"1999","unstructured":"Drent, M. et al. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur. Respir. J. 13, 1338\u20131344 (1999).","journal-title":"Eur. Respir. J."},{"key":"96_CR192","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/thx.44.1.6","volume":"44","author":"K Ward","year":"1989","unstructured":"Ward, K., O\u2019Connor, C., Odlum, C. & Fitzgerald, M. X. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 44, 6\u201312 (1989).","journal-title":"Thorax"},{"key":"96_CR193","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1183\/09031936.03.00010403","volume":"21","author":"MW Ziegenhagen","year":"2003","unstructured":"Ziegenhagen, M. W., Rothe, M. E., Schlaak, M. & M\u00fcller-Quernheim, J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur. Respir. J. 21, 407\u2013413 (2003).","journal-title":"Eur. Respir. J."},{"key":"96_CR194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2007.08.010","volume":"102","author":"S Paramothayan","year":"2008","unstructured":"Paramothayan, S. & Lasserson, T. Treatments for pulmonary sarcoidosis. Respir. Med. 102, 1\u20139 (2008).","journal-title":"Respir. Med."},{"key":"96_CR195","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","volume":"138S","author":"CE Broos","year":"2018","unstructured":"Broos, C. E. et al. No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis. Respir. Med. 138S, S31\u2013S37 (2018).","journal-title":"Respir. Med."},{"key":"96_CR196","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/rheumatology\/39.7.707","volume":"39","author":"M Conron","year":"2000","unstructured":"Conron, M., Young, C. & Beynon, H. L. Calcium metabolism in sarcoidosis and its clinical implications. Rheumatology 39, 707\u2013713 (2000).","journal-title":"Rheumatology"},{"key":"96_CR197","first-page":"113","volume":"30","author":"RP Baughman","year":"2013","unstructured":"Baughman, R. P., Janovcik, J., Ray, M., Sweiss, N. & Lower, E. E. Calcium and vitamin D metabolism in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 30, 113\u2013120 (2013).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR198","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1055\/s-0030-1262215","volume":"31","author":"RR Burke","year":"2010","unstructured":"Burke, R. R., Rybicki, B. A. & Rao, D. S. Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin. Respir. Crit. Care Med. 31, 474\u2013484 (2010).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"96_CR199","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","volume":"41","author":"RP Baughman","year":"2013","unstructured":"Baughman, R. P., Nunes, H., Sweiss, N. J. & Lower, E. E. Established and experimental medical therapy of pulmonary sarcoidosis. Eur. Respir. J. 41, 1424\u20131438 (2013).","journal-title":"Eur. Respir. J."},{"key":"96_CR200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2015.11.007","volume":"110","author":"RP Baughman","year":"2016","unstructured":"Baughman, R. P., Barney, J. B., O\u2019Hare, L. & Lower, E. E. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Respir. Med. 110, 66\u201372 (2016).","journal-title":"Respir. Med."},{"key":"96_CR201","first-page":"185","volume":"19","author":"MW Ziegenhagen","year":"2002","unstructured":"Ziegenhagen, M. W., Rothe, M. E., Zissel, G. & Muller-Quernheim, J. Exaggerated TNFalpha release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 19, 185\u2013190 (2002).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.122.1.227","volume":"122","author":"RP Baughman","year":"2002","unstructured":"Baughman, R. P., Judson, M. A., Teirstein, A. S., Moller, D. R. & Lower, E. E. Thalidomide for chronic sarcoidosis. Chest 122, 227\u2013232 (2002).","journal-title":"Chest"},{"key":"96_CR203","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1378\/chest.14-2529","volume":"148","author":"MJ Giv","year":"2015","unstructured":"Giv, M. J., Yoosuff, A. & Bazargan, A. Use of lenalidomide in 5q-myelodysplastic syndrome provides novel treatment prospects in management of pulmonary sarcoidosis. Chest 148, e35\u2013e37 (2015).","journal-title":"Chest"},{"key":"96_CR204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2567.1997.00246.x","volume":"91","author":"DR Moller","year":"1997","unstructured":"Moller, D. R. et al. Inhibition of human interleukin-12 production by pentoxifylline. Immunology 91, 197\u2013203 (1997).","journal-title":"Immunology"},{"key":"96_CR205","first-page":"121","volume":"26","author":"MK Park","year":"2009","unstructured":"Park, M. K. et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 26, 121\u2013131 (2009).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2017.10.005","volume":"128","author":"JP Gomes","year":"2018","unstructured":"Gomes, J. P., Watad, A. & Shoenfeld, Y. Nicotine and autoimmunity: the lotus\u2019 flower in tobacco. Pharmacol. Res. 128, 101\u2013109 (2018).","journal-title":"Pharmacol. Res."},{"key":"96_CR207","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1378\/chest.12-0383","volume":"143","author":"MW Julian","year":"2013","unstructured":"Julian, M. W. et al. Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis. Chest 143, 461\u2013470 (2013).","journal-title":"Chest"},{"key":"96_CR208","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/1744666X.2016.1175301","volume":"12","author":"LA Saketkoo","year":"2016","unstructured":"Saketkoo, L. A. & Baughman, R. P. Biologic therapies in the treatment of sarcoidosis. Expert Rev. Clin. Immunol. 12, 817\u2013825 (2016).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"96_CR209","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman, R. P. et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am. J. Respir. Crit. Care Med. 174, 795\u2013802 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR210","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","volume":"44","author":"MA Judson","year":"2014","unstructured":"Judson, M. A. et al. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur. Respir. J. 44, 1296\u20131307 (2014).","journal-title":"Eur. Respir. J."},{"key":"96_CR211","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00337-10","volume":"18","author":"MJ Loza","year":"2011","unstructured":"Loza, M. J. et al. Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis. Clin. Vaccine Immunol. 18, 931\u2013939 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"96_CR212","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","volume":"31","author":"MA Judson","year":"2008","unstructured":"Judson, M. A. et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur. Respir. J. 31, 1189\u20131196 (2008).","journal-title":"Eur. Respir. J."},{"key":"96_CR213","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000328738","volume":"83","author":"KE Hostettler","year":"2012","unstructured":"Hostettler, K. E., Studler, U., Tamm, M. & Brutsche, M. H. Long-term treatment with infliximab in patients with sarcoidosis. Respiration 83, 218\u2013224 (2012).","journal-title":"Respiration"},{"key":"96_CR214","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","volume":"25","author":"R Perez-Alvarez","year":"2013","unstructured":"Perez-Alvarez, R., Perez-de-Lis, M. & Ramos-Casals, M. Biologics-induced autoimmune diseases. Curr. Opin. Rheumatol. 25, 56\u201364 (2013).","journal-title":"Curr. Opin. Rheumatol."},{"key":"96_CR215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MCP.0000000000000498","volume":"24","author":"ED Crouser","year":"2018","unstructured":"Crouser, E. D. Role of imbalance between Th17 and regulatory T cells in sarcoidosis. Curr. Opin. Pulm. Med. 24, 521\u2013526 (2018).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"96_CR216","doi-asserted-by":"crossref","first-page":"BIO52","DOI":"10.1167\/iovs.16-21291","volume":"58","author":"DA Culver","year":"2017","unstructured":"Culver, D. A. et al. Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain. Invest. Ophthalmol. Vis. Sci. 58, BIO52\u2013BIO60 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"96_CR217","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000486964","volume":"95","author":"H Lingner","year":"2018","unstructured":"Lingner, H. et al. Short-term effects of a multimodal 3-week inpatient pulmonary rehabilitation programme for patients with sarcoidosis: the ProKaSaRe Study. Respiration 95, 343\u2013353 (2018).","journal-title":"Respiration"},{"key":"96_CR218","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1183\/09031936.00175511","volume":"39","author":"OA Shlobin","year":"2012","unstructured":"Shlobin, O. A. & Nathan, S. D. Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation. Eur. Respir. J. 39, 1520\u20131533 (2012).","journal-title":"Eur. Respir. J."},{"key":"96_CR219","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","volume":"145","author":"RP Baughman","year":"2013","unstructured":"Baughman, R. P. et al. Bosentan for sarcoidosis associated pulmonary hypertension: A double-blind placebo controlled randomized trial. Chest 145, 810\u2013817 (2013).","journal-title":"Chest"},{"key":"96_CR220","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ccm.2015.08.013","volume":"36","author":"M Drent","year":"2015","unstructured":"Drent, M., Strookappe, B., Hoitsma, E. & De Vries, J. Consequences of sarcoidosis. Clin. Chest Med. 36, 727\u2013737 (2015).","journal-title":"Clin. Chest Med."},{"key":"96_CR221","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1370\/afm.245","volume":"2","author":"F Borrell-Carrio","year":"2004","unstructured":"Borrell-Carrio, F., Suchman, A. L. & Epstein, R. M. The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. Ann. Fam. Med. 2, 576\u2013582 (2004).","journal-title":"Ann. Fam. Med."},{"key":"96_CR222","first-page":"111","volume":"11","author":"MA Judson","year":"2017","unstructured":"Judson, M. A. Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease. Expert Rev. Respir. Med. 11, 111\u2013118 (2017).","journal-title":"Respir. Med."},{"key":"96_CR223","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","volume":"109","author":"MA Judson","year":"2015","unstructured":"Judson, M. A., Chaudhry, H., Louis, A., Lee, K. & Yucel, R. The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir. Med. 109, 526\u2013531 (2015).","journal-title":"Respir. Med."},{"key":"96_CR224","doi-asserted-by":"crossref","first-page":"00085","DOI":"10.1183\/23120541.00085-2017","volume":"4","author":"LA Saketkoo","year":"2018","unstructured":"Saketkoo, L. A. et al. Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis. ERJ Open Res. 4, 00085-2017 (2018).","journal-title":"ERJ Open Res."},{"key":"96_CR225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ejp.1340","volume":"23","author":"A Shires","year":"2018","unstructured":"Shires, A., Sharpe, L. & Newton John, T. The relative efficacy of mindfulness versus distraction: the moderating role of attentional bias. Eur. J. Pain 23, 727\u2013738 (2018).","journal-title":"Eur. J. Pain"},{"key":"96_CR226","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00408-018-0144-4","volume":"196","author":"CC Moor","year":"2018","unstructured":"Moor, C. C. et al. Needs, perceptions and education in sarcoidosis: a live interactive survey of patients and partners. Lung 196, 569\u2013575 (2018).","journal-title":"Lung"},{"key":"96_CR227","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets, E. M., Garssen, B., Bonke, B. & De Haes, J. C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39, 315\u2013325 (1995).","journal-title":"J. Psychosom. Res."},{"key":"96_CR228","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/rheumatology\/kep287","volume":"48","author":"P Minnock","year":"2009","unstructured":"Minnock, P., Kirwan, J. & Bresnihan, B. Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis. Rheumatology 48, 1533\u20131536 (2009).","journal-title":"Rheumatology"},{"key":"96_CR229","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0961203316654767","volume":"26","author":"MA Petri","year":"2017","unstructured":"Petri, M. A., Martin, R. S., Scheinberg, M. A. & Furie, R. A. Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod. Lupus 26, 27\u201337 (2017).","journal-title":"Lupus"},{"key":"96_CR230","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/art.20839","volume":"51","author":"S Abad","year":"2004","unstructured":"Abad, S. et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum. 51, 974\u2013982 (2004).","journal-title":"Arthritis Rheum."},{"key":"96_CR231","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1440-1843.2012.02134.x","volume":"17","author":"S De Boer","year":"2012","unstructured":"De Boer, S. & Wilsher, M. L. Validation of the Sarcoidosis Health Questionnaire in a non-US population. Respirology 17, 519\u2013524 (2012).","journal-title":"Respirology"},{"key":"96_CR232","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","volume":"9","author":"J De Vries","year":"2004","unstructured":"De Vries, J., Michielsen, H., Van Heck, G. L. & Drent, M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br. J. Health Psychol. 9, 279\u2013291 (2004).","journal-title":"Br. J. Health Psychol."},{"key":"96_CR233","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MCP.0b013e3283547092","volume":"18","author":"ML Wilsher","year":"2012","unstructured":"Wilsher, M. L. Psychological stress in sarcoidosis. Curr. Opin. Pulm. Med. 18, 524\u2013527 (2012).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"96_CR234","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.rmed.2018.03.021","volume":"144S","author":"BS Benn","year":"2018","unstructured":"Benn, B. S. et al. Sleep disturbance and symptom burden in sarcoidosis. Respir. Med. 144S, S35\u2013S40 (2018).","journal-title":"Respir. Med."},{"key":"96_CR235","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.sleep.2014.12.025","volume":"16","author":"A Bosse-Henck","year":"2015","unstructured":"Bosse-Henck, A., Wirtz, H. & Hinz, A. Subjective sleep quality in sarcoidosis. Sleep Med. 16, 570\u2013576 (2015).","journal-title":"Sleep Med."},{"key":"96_CR236","doi-asserted-by":"crossref","first-page":"6853948","DOI":"10.1155\/2018\/6853948","volume":"2018","author":"A Hinz","year":"2018","unstructured":"Hinz, A., Geue, K., Zenger, M., Wirtz, H. & Bosse-Henck, A. Daytime sleepiness in patients diagnosed with sarcoidosis compared with the general population. Can. Respir. J. 2018, 6853948 (2018).","journal-title":"Can. Respir. J."},{"key":"96_CR237","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1378\/chest.15-0584","volume":"148","author":"C Lal","year":"2015","unstructured":"Lal, C., Medarov, B. I. & Judson, M. A. Interrelationship between sleep-disordered breathing and sarcoidosis. Chest 148, 1105\u20131114 (2015).","journal-title":"Chest"},{"key":"96_CR238","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/ajrccm.163.2.2004177","volume":"163","author":"B Chang","year":"2001","unstructured":"Chang, B. et al. Depression in sarcoidosis. Am. J. Respir. Crit. Care Med. 163, 329\u2013334 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR239","first-page":"36","volume":"27","author":"J Ireland","year":"2010","unstructured":"Ireland, J. & Wilsher, M. Perceptions and beliefs in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 27, 36\u201342 (2010).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"96_CR240","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamainternmed.2017.1923","volume":"177","author":"G Elwyn","year":"2017","unstructured":"Elwyn, G., Cochran, N. & Pignone, M. Shared decision making \u2014 the importance of diagnosing preferences. JAMA Intern. Med. 177, 1239\u20131240 (2017).","journal-title":"JAMA Intern. Med."},{"key":"96_CR241","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","volume":"53","author":"AN Dubovsky","year":"2012","unstructured":"Dubovsky, A. N., Arvikar, S., Stern, T. A. & Axelrod, L. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics 53, 103\u2013115 (2012).","journal-title":"Psychosomatics"},{"key":"96_CR242","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/014107680109401103","volume":"94","author":"J Rees","year":"2001","unstructured":"Rees, J., O\u2019Boyle, C. & MacDonagh, R. Quality of life: impact of chronic illness on the partner. J. R. Soc. Med. 94, 563\u2013566 (2001).","journal-title":"J. R. Soc. Med."},{"key":"96_CR243","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cncr.29223","volume":"121","author":"H Sklenarova","year":"2015","unstructured":"Sklenarova, H. et al. When do we need to care about the caregiver? Supportive care needs, anxiety, and depression among informal caregivers of patients with cancer and cancer survivors. Cancer 121, 1513\u20131519 (2015).","journal-title":"Cancer"},{"key":"96_CR244","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.131251","volume":"41","author":"LA Saketkoo","year":"2014","unstructured":"Saketkoo, L. A. et al. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases. J.\u00a0Rheumatol. 41, 792\u2013798 (2014).","journal-title":"J. Rheumatol."},{"key":"96_CR245","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.rmed.2018.09.016","volume":"144S","author":"EV Arkema","year":"2018","unstructured":"Arkema, E. V., Eklund, A., Grunewald, J. & Bruze, G. Work ability before and after sarcoidosis diagnosis in Sweden. Respir. Med. 144S, S7\u2013S12 (2018).","journal-title":"Respir. Med."},{"key":"96_CR246","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/14737167.2015.1065733","volume":"15","author":"PP Kawalec","year":"2015","unstructured":"Kawalec, P. P. & Malinowski, K. P. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland. Expert Rev. Pharmacoecon. Outcomes Res. 15, 667\u2013673 (2015).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"96_CR247","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1080\/13696998.2017.1351371","volume":"20","author":"JB Rice","year":"2017","unstructured":"Rice, J. B. et al. Economic burden of sarcoidosis in a commercially-insured population in the United States. J. Med. Econ. 20, 1048\u20131055 (2017).","journal-title":"J. Med. Econ."},{"key":"96_CR248","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1403494817713650","volume":"46","author":"M Borgh","year":"2018","unstructured":"Borgh, M., Eek, F., Wagman, P. & Hakansson, C. Organisational factors and occupational balance in working parents in Sweden. Scand. J. Public Health 46, 409\u2013416 (2018).","journal-title":"Scand. J. Public Health"},{"key":"96_CR249","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00484-004-0246-y","volume":"49","author":"SE Markham","year":"2005","unstructured":"Markham, S. E. & Markham, I. S. Biometeorological effects on worker absenteeism. Int. J. Biometeorol. 49, 317\u2013324 (2005).","journal-title":"Int. J. Biometeorol."},{"key":"96_CR250","first-page":"108","volume":"38","author":"C Muller","year":"2015","unstructured":"Muller, C. California State University catastrophic (Cat) leave donation program: demographics, economic security, and social equity. J. Health Hum. Serv. Adm. 38, 108\u2013159 (2015).","journal-title":"J. Health Hum. Serv. Adm."},{"key":"96_CR251","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3899\/jrheum.131145","volume":"41","author":"H Alexanderson","year":"2014","unstructured":"Alexanderson, H. et al. Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis \u2014 a randomized controlled single-blinded study with a 2-year followup. J. Rheumatol. 41, 1124\u20131132 (2014).","journal-title":"J. Rheumatol."},{"key":"96_CR252","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1097\/HCR.0000000000000360","volume":"38","author":"E Bernardi","year":"2018","unstructured":"Bernardi, E., Pomidori, L., Cassutti, F. & Cogo, A. Home-based, moderate-intensity exercise training using a metronome improves the breathing pattern and oxygen saturation during exercise in patients with COPD. J. Cardiopulm. Rehabil. Prev. 38, E16\u2013E18 (2018).","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"96_CR253","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201511-2152OC","volume":"194","author":"AM Russell","year":"2016","unstructured":"Russell, A. M. et al. Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 194, 989\u2013997 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR254","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMsr1503323","volume":"377","author":"RV Tuckson","year":"2017","unstructured":"Tuckson, R. V., Edmunds, M. & Hodgkins, M. L. Telehealth. N. Engl. J. Med. 377, 1585\u20131592 (2017).","journal-title":"N. Engl. J. Med."},{"key":"96_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.androl.2018.05.002","author":"MS Bolat","year":"2018","unstructured":"Bolat, M. S., Celik, B., Celik, H. K. & Akdeniz, E. The impact of thoracotomy on psychological and sexual function in men with lung cancer. Rev. Int. Androl. https:\/\/doi.org\/10.1016\/j.androl.2018.05.002 (2018).","journal-title":"Rev. Int. Androl."},{"key":"96_CR256","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jpsychores.2018.10.011","volume":"115","author":"AM Hassanin","year":"2018","unstructured":"Hassanin, A. M., Ismail, N. N., El Guindi, A. & Sowailam, H. A. The emotional burden of chronic skin disease dominates physical factors among women, adversely affecting quality of life and sexual function. J. Psychosom. Res. 115, 53\u201357 (2018).","journal-title":"J. Psychosom. Res."},{"key":"96_CR257","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/msc.1105","volume":"13","author":"G Ostlund","year":"2015","unstructured":"Ostlund, G., Bjork, M., Valtersson, E. & Sverker, A. Lived experiences of sex life difficulties in men and women with early RA \u2014 the Swedish TIRA Project. Musculoskeletal Care 13, 248\u2013257 (2015).","journal-title":"Musculoskeletal Care"},{"key":"96_CR258","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijnurstu.2018.07.017","volume":"87","author":"S Fourie","year":"2018","unstructured":"Fourie, S., Jackson, D. & Aveyard, H. Living with inflammatory bowel disease: a review of qualitative research studies. Int. J. Nurs. Stud 87, 149\u2013156 (2018).","journal-title":"Int. J. Nurs. Stud"},{"key":"96_CR259","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1573398X11666150619182624","volume":"11","author":"S Mittoo","year":"2015","unstructured":"Mittoo, S. et al. Patient perspectives in OMERACT provide an anchor for future metric development and improved approaches to healthcare delivery in connective tissue disease related interstitial lung disease (CTD-ILD). Curr. Respir. Med. Rev. 11, 175\u2013183 (2015).","journal-title":"Curr. Respir. Med. Rev."},{"key":"96_CR260","first-page":"8","volume":"8","author":"CE Cox","year":"2003","unstructured":"Cox, C. E., Donohue, J. F., Brown, C. D., Kataria, Y. P. & Judson, M. A. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am. J. Respir. Crit. Care Med. 8, 8 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR261","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","volume":"68","author":"AS Patel","year":"2013","unstructured":"Patel, A. S. et al. The development and validation of the King\u2019s Sarcoidosis Questionnaire for the assessment of health status. Thorax 68, 57\u201365 (2013).","journal-title":"Thorax"},{"key":"96_CR262","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","volume":"191","author":"MA Judson","year":"2015","unstructured":"Judson, M. A. et al. Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure. Am. J. Respir. Crit. Care Med. 191, 786\u2013795 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"96_CR263","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MCP.0000000000000496","volume":"24","author":"C Hendriks","year":"2018","unstructured":"Hendriks, C., Drent, M., Elfferich, M. & De Vries, J. The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases. Curr. Opin. Pulm. Med. 24, 495\u2013503 (2018).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"96_CR264","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/ejn.13701","volume":"46","author":"C Fauchon","year":"2017","unstructured":"Fauchon, C. et al. Does an observer\u2019s empathy influence my pain? Effect of perceived empathetic or unempathetic support on a pain test. Eur. J. Neurosci. 46, 2629\u20132637 (2017).","journal-title":"Eur. J. Neurosci."},{"key":"96_CR265","doi-asserted-by":"publisher","DOI":"10.1007\/s13187-018-1439-0","author":"J Nixon","year":"2018","unstructured":"Nixon, J. et al. Communicating actively responding empathically (CARE): comparison of communication training workshops for health professionals working in cancer care. J. Cancer Educ. https:\/\/doi.org\/10.1007\/s13187-018-1439-0 (2018).","journal-title":"J. Cancer Educ."},{"key":"96_CR266","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley, L. et al. 2017 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 69, 1521\u20131537 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"96_CR267","first-page":"1","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh, J. A. et al. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 68, 1\u201326 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"96_CR268","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/17476348.2016.1227244","volume":"10","author":"B Strookappe","year":"2016","unstructured":"Strookappe, B. et al. Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Rev. Respir. Med. 10, 1057\u20131068 (2016).","journal-title":"Expert Rev. Respir. Med."},{"key":"96_CR269","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","volume":"6","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo, P. et al. Pulmonary sarcoidosis. Lancet Respir. Med. 6, 389\u2013402 (2018).","journal-title":"Lancet Respir. Med."},{"key":"96_CR270","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","volume":"12","author":"DR Moller","year":"2015","unstructured":"Moller, D. R. et al. Rationale and design of the genomic research in alpha-1 antitrypsin deficiency and sarcoidosis (GRADS) study. Sarcoidosis protocol. Ann. Am. Thorac. Soc. 12, 1561\u20131571 (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"96_CR271","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3389\/fimmu.2017.01130","volume":"8","author":"Y Kaiser","year":"2017","unstructured":"Kaiser, Y. et al. Mass cytometry identifies distinct lung CD4+ T cell patterns in Lofgren\u2019s syndrome and non-Lofgren\u2019s syndrome sarcoidosis. Front. Immunol. 8, 1130 (2017).","journal-title":"Front. Immunol."},{"key":"96_CR272","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1513\/AnnalsATS.201707-565OT","volume":"14","author":"DR Moller","year":"2017","unstructured":"Moller, D. R. et al. Genetic, immunologic, and environmental basis of sarcoidosis. Ann. Am. Thorac. Soc. 14, S429\u2013S436 (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"96_CR273","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1513\/AnnalsATS.201707-567OT","volume":"14","author":"ED Crouser","year":"2017","unstructured":"Crouser, E. D. et al. Application of \u201comics\u201d and systems biology to sarcoidosis research. Ann. Am. Thorac. Soc. 14, S445\u2013S451 (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"96_CR274","doi-asserted-by":"crossref","DOI":"10.1186\/s12948-015-0025-9","volume":"13","author":"F Cinetto","year":"2015","unstructured":"Cinetto, F., Compagno, N., Scarpa, R., Malipiero, G. & Agostini, C. Rituximab in refractory sarcoidosis: a single centre experience. Clin. Mol. Allergy 13, 19 (2015).","journal-title":"Clin. Mol. Allergy"},{"key":"96_CR275","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","volume":"43","author":"NJ Sweiss","year":"2014","unstructured":"Sweiss, N. J. et al. Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur. Respir. J. 43,\u00a01525\u20131528 (2014).","journal-title":"Eur. Respir. J."},{"key":"96_CR276","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1183\/09031936.00057407","volume":"31","author":"SS Birring","year":"2008","unstructured":"Birring, S. S. et al. The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur. Respir. J. 31,\u00a01013\u20131018 (2008).","journal-title":"Eur. Respir. J."},{"key":"96_CR277","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.chest.2018.06.038","volume":"154","author":"SS Birring","year":"2018","unstructured":"Birring, S. S. et al. Treatment of interstitial lung disease associated cough: CHEST Guideline and Expert Panel Report. Chest 154, 904\u2013917 (2018).","journal-title":"Chest"},{"key":"96_CR278","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0037-1602589","volume":"38","author":"MA Judson","year":"2017","unstructured":"Judson, M. A. Quality of life in sarcoidosis. Semin. Respir. Crit. Care Med. 38, 546\u2013558 (2017).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"96_CR279","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccm.2008.03.009","volume":"29","author":"MA Judson","year":"2008","unstructured":"Judson, M. A. The diagnosis of sarcoidosis. Clin. Chest Med. 29, 415\u2013427 (2008).","journal-title":"Clin. Chest Med."},{"key":"96_CR280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","volume":"49","author":"MA Judson","year":"2015","unstructured":"Judson, M. A. The clinical features of sarcoidosis: a comprehensive review. Clin. Rev. Allergy Immunol. 49, 63\u201378 (2015).","journal-title":"Clin. Rev. Allergy Immunol."}],"updated-by":[{"DOI":"10.1038\/s41572-019-0107-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000}}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0096-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:41:35Z","timestamp":1721479295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0096-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":280,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1038\/s41572-019-0096-x","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"22 May 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.R.M. is the Chairman and Chief Technology Officer of Sarcoidosis Diagnostic Testing, LLC. J.M.-Q. is supported by the German Research Foundation (Mu692\/12) and Bristol-Myers-Squibb for investigator-initiated trials in sarcoidosis. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}